MONKEYPOX VACCINE CLINICAL TRIAL

$114.98M USD

Funder	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization	Leidos Biomedical Research, Inc.
Country	United States
Start Date	Sep 19, 2022
End Date	Sep 18, 2024
Duration	730 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10710305`

Grant Description

To support a Phase II clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses.